{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Dallas",
      "state": "GA",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "66878",
      "recalling_firm": "Fossil Fuel Products, LLC",
      "address_1": "138 Sedgefield Overlook",
      "address_2": "N/A",
      "postal_code": "30157",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Nationwide.",
      "recall_number": "D-1248-2014",
      "product_description": "RezzRX capsules, Single Blister Pack and 20 count bottle,  Distributed By: Fossil Fuel Products, LLC Atlanta, GA 30309",
      "product_quantity": "50,300 capsules",
      "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Fossil Fuel Products, is recalling  RezzRX due to undeclared  hydroxylthiohomosildenafil and aminotadalafil.",
      "recall_initiation_date": "20131118",
      "center_classification_date": "20140418",
      "termination_date": "20150529",
      "report_date": "20140430",
      "code_info": "Lots QL110408B046, QL110714A102  Exp. 11/13",
      "more_code_info": ""
    }
  ]
}